From the patient perspective: The economic value of seasonal and H1N1 influenza vaccination
| Autor: | Rachel R. Bailey, Julie M. Donohue, Richard K. Zimmerman, Ann E. Wiringa, Bruce Y. Lee, Kristina M. Bacon |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Adolescent Influenza vaccine Cost-Benefit Analysis Decision Making Orthomyxoviridae Attack rate medicine.disease_cause Article Disease Outbreaks Young Adult Influenza A Virus H1N1 Subtype Environmental health Intervention (counseling) Influenza Human Influenza A virus medicine Humans Computer Simulation Young adult General Veterinary General Immunology and Microbiology biology Cost–benefit analysis business.industry Vaccination Public Health Environmental and Occupational Health Middle Aged biology.organism_classification Infectious Diseases Influenza Vaccines Immunology Molecular Medicine business |
| Zdroj: | Vaccine. 29:2149-2158 |
| ISSN: | 0264-410X |
| Popis: | Although studies have suggested that a patient's perceived cost-benefit of a medical intervention could affect his or her utilization of the intervention, the economic value of influenza vaccine from the patient's perspective remains unclear. Therefore, we developed a stochastic decision analytic computer model representing an adult's decision of whether to get vaccinated. Different scenarios explored the impact of the patient being insured versus uninsured, influenza attack rate, vaccine administration costs and vaccination time costs. Results indicated that the cost of avoiding influenza was fairly low (with one driver being required vaccination time). To encourage vaccination, decision makers may want to focus on ways to reduce this time, such as vaccinating at work, churches, or other normally frequented locations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect